Pet Diabetes Care Global Market By Animal Type, By Distribution Channel, By Device Type, By End User, Regional Outlook and Forecast 2024-2033 | Zoetis Inc., Covetrus Inc., Allison Medical Inc., UltiMed Inc., Apotex Inc.

Overview and Scope
Pet diabetes care is used to treat pets suffering from diabetes, which may also cause other diseases such as heart disease, pancreatitis, urinary tract infections, kidney disease, and skin infections. Diabetes develops when a pet’s body produces insufficient insulin, stops generating it altogether, or uses it improperly, which hinders the body from converting food into energy.

Sizing and Forecast
The pet diabetes care market size has grown strongly in recent years. It will grow from $2.04 billion in 2023 to $2.23 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to growing awareness of pet health, advancements in veterinary medicine, prevalence of diabetes in pets, humanization of pets, increased focus on pet nutrition, awareness campaigns by veterinary organizations, availability of insulin and medications.

The pet diabetes care market size is expected to see strong growth in the next few years. It will grow to $3.21 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to rise in pet insurance adoption, customized diabetes management plans, focus on preventive pet healthcare, globalization of pet health trends, increasing investments in pet healthcare research, rising consumer affluence. Major trends in the forecast period include advancements in veterinary diagnostics, focus on pet obesity management, innovation in insulin delivery systems, rise in pet insurance coverage, increased availability of specialized pet foods:, telemedicine and remote monitoring, collaborations in veterinary medicine.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Segmentation & Regional Insights
The pet diabetes care market covered in this report is segmented –
1) By Drug Type: Insulin Therapy, Oral Medication
2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices
3) By Animal Type: Canine, Feline, Other Animal Types
4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

North America was the largest region in the pet diabetes care market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

Major Driver Impacting Market Growth
An increase in pet adoption is expected to propel the growth of the pet diabetes care market going forward. Pet adoption is the process of obtaining a pet from a shelter or rescue that has been left behind by its prior owners, as opposed to buying a pet from a pet store, breeder, or other individuals. Diabetes is increasingly being diagnosed in pets every year, which is partly because their lifestyles mirror ours in that they are more sedentary and rely more heavily on processed foods. For instance, according to the survey conducted by the American Pet Products Association (APPA), a US-based leading trade group for the pet business, in June 2021, 70% of American homes have pets, up from 67% in the 2019-2020 survey. A new pet was adopted by 14% of all respondents (pet owners and non-pet owners combined). Therefore, an increase in pet adoption is driving the growth of the pet diabetes care market.

Key Industry Players
Major companies operating in the pet diabetes care market report are C.H. Boehringer Sohn AG & Co. KG, Becton Dickinson and Company, Merck & Co Inc., Zoetis Inc., Trividia Health Inc., Allison Medical Inc., UltiMed Inc., Apotex Inc., Henry Schein VET GmbH, Medtrust Holdings Inc., i-SENS Inc., Taidoc Technology Corp., Covetrus Inc., ALR Technologies Inc., Vet Innovations Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG, Bayer AG, Dexcom Inc., LifeScan Inc., Medtronic plc, Novo Nordisk A/S, Sanofi S.A., Senseonics Holdings Inc., Tandem Diabetes Care Inc., Terumo Corporation, Animas Corporation, Insulet Corporation, Roche Diabetes Care Inc.

The pet diabetes care market report table of contents includes:
1. Executive Summary